As previously demonstrated [27, 28], letrozole treatment of pubertal female mice resulted in many features of metabolic dysregulation observed in women with PCOS including weight gain, increased FBG and insulin levels, and insulin resistance. The gene discussed is INS; the disease is polycystic ovary syndrome.